Innospec Inc. (NASDAQ:IOSP – Free Report) – Analysts at Seaport Res Ptn cut their Q3 2025 earnings per share (EPS) estimates for Innospec in a research note issued on Friday, October 17th. Seaport Res Ptn analyst M. Harrison now forecasts that the specialty chemicals company will post earnings of $1.03 per share for the quarter, down from their prior forecast of $1.12. The consensus estimate for Innospec’s current full-year earnings is $6.18 per share. Seaport Res Ptn also issued estimates for Innospec’s Q4 2025 earnings at $1.37 EPS and FY2025 earnings at $5.08 EPS.
Several other research analysts have also weighed in on IOSP. Zacks Research upgraded Innospec from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Wall Street Zen lowered Innospec from a “buy” rating to a “hold” rating in a report on Sunday. Finally, Weiss Ratings upgraded Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.
Innospec Stock Up 0.4%
Shares of Innospec stock opened at $74.39 on Monday. Innospec has a 12 month low of $73.58 and a 12 month high of $128.35. The business has a fifty day simple moving average of $81.18 and a 200 day simple moving average of $84.46. The stock has a market cap of $1.85 billion, a PE ratio of 95.37 and a beta of 1.04.
Innospec (NASDAQ:IOSP – Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The specialty chemicals company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.09. Innospec had a return on equity of 10.89% and a net margin of 1.08%.The business had revenue of $439.70 million during the quarter, compared to analysts’ expectations of $440.70 million. During the same period in the previous year, the firm earned $1.39 earnings per share. The firm’s quarterly revenue was up 1.1% compared to the same quarter last year.
Institutional Trading of Innospec
Institutional investors have recently modified their holdings of the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new stake in shares of Innospec in the second quarter valued at about $28,000. Tsfg LLC bought a new stake in shares of Innospec in the first quarter valued at about $35,000. EverSource Wealth Advisors LLC lifted its holdings in shares of Innospec by 1,159.5% in the second quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock valued at $44,000 after purchasing an additional 487 shares in the last quarter. Blue Trust Inc. lifted its holdings in shares of Innospec by 38.3% in the second quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company’s stock valued at $57,000 after purchasing an additional 186 shares in the last quarter. Finally, State of Wyoming raised its holdings in Innospec by 27.5% during the second quarter. State of Wyoming now owns 801 shares of the specialty chemicals company’s stock worth $67,000 after acquiring an additional 173 shares in the last quarter. 96.64% of the stock is currently owned by institutional investors.
About Innospec
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Featured Articles
- Five stocks we like better than Innospec
- Bank Stocks – Best Bank Stocks to Invest In
- Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet
- How to Plot Fibonacci Price Inflection Levels
- 3 High-Yield Banks for Investors to Buy on the Dip
- ESG Stocks, What Investors Should Know
- 5 Surprising Stocks Set to Benefit From a Future Robotics Boom
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.